Status:
UNKNOWN
Helicobacter Pylori Empiric Treatment in Ulcer Bleeding
Lead Sponsor:
Hospital de Sabadell
Collaborating Sponsors:
Corporacion Parc Tauli
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Conditions:
Peptic Ulcer Hemorrhage
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The goal of the study is to compare the effectiveness of empirical Helicobacter pylori treatment compared with treatment depending on diagnostic tests for Helicobacter pylori in patients with Upper ga...
Eligibility Criteria
Inclusion
- Patients older than 18.
- Informed Consent signed.
- Diagnosis of no variceal upper gastrointestinal bleeding secondary to a duodenal ulcer, erosive duodenitis or gastric ulcer.
- Life expectancy longer than 6 months.
- Able to attend further clinical controls.
- Absence of the following exclusion criteria.
Exclusion
- Previous eradication treatment.
- Use of antibiotics 2 weeks prior to inclusion.
- Need for Antisecretor treatment that cannot be stopped to perform the breath test.
- Pregnancy or breastfeeding.
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2010
Estimated Enrollment :
178 Patients enrolled
Trial Details
Trial ID
NCT00687336
Start Date
March 1 2008
End Date
May 1 2010
Last Update
July 8 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Sabadell, Institut Universitari Parc Tauli
Sabadell, Barcelona, Spain, 08208